Key result
Electrocardiographic markers of repolarization and conduction have been developed to predict malignant ventricular arrhythmogenesis and sudden cardiac death, but require further clinical validation.
Why the study?
Extensive investigations have generated novel ECG markers of arrhythmogenesis and sudden cardiac death, but their clinical validity across various cardiac pathologies requires further confirmation.
This review highlights the evolution and potential clinical utility of novel ECG conduction and repolarization markers for predicting sudden cardiac death.
These markers should not guide SCD risk assessment yet; leaves open need for prospective validation trials.
The QT interval along with its heart rate corrected form (QTc) are well-established ECG markers that have been found to be associated with malignant ventricular arrhythmogenesis. However, extensive preclinical and clinical investigations over the years have allowed for novel clinical ECG markers to be generated as predictors of arrhythmogenesis and sudden cardiac death. Repolarization markers include the older QTc, QT dispersion and newer Tpeak - Tend intervals, (Tpeak - Tend) / QT ratios, T-wave alternans (TWA), microvolt TWA and T-wave area dispersion. Meanwhile, conduction markers dissecting the QRS complex, such as QRS dispersion (QRSD) and fragmented QRS, were also found to correlate conduction velocity and unidirectional block with re-entrant substrates in various cardiac conditions. Both repolarization and conduction parameters can be combined into the excitation wavelength (λ). A surrogate marker for λ is the index of Cardiac Electrophysiological Balance (iCEB: QT / QRSd). Other markers based on conduction-repolarization are [QRSD x (Tpeak-Tend) / QRSd] and [QRSD x (Tpeak-Tend) / (QRSd x QT)]. Advancement in technology permitted sophisticated electrophysiological analyses such as principal component analysis and periodic repolarization dynamics to further improve risk stratification. This was closely followed by other novel indices including ventricular ectopic QRS interval, the f99 index and EntropyXQT, which integrates mathematical and physical calculations for determining the risk markers. Though proven to be effective in limited patient cohorts, more clinical studies across different cardiac pathologies are required to confirm their validity. As such, this review seeks to encapsulate the development of old and new ECG markers along with their associated utility and shortcomings in clinical practice.
No takes yet. Share an insight, caveat, or question.
Reynard et al. (2019) conducted a review in Sudden cardiac death and malignant ventricular arrhythmogenesis. Electrocardiographic conduction and repolarization markers was evaluated. Electrocardiographic markers of repolarization and conduction have been developed to predict malignant ventricular arrhythmogenesis and sudden cardiac death, but require further clinical validation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: